Suppr超能文献

帕金森病痴呆的痴呆评定量表评估。

Evaluation of dementia rating scales in Parkinson's disease dementia.

机构信息

Emory University School of Medicine, 101 Woodruff Circle, Atlanta, GA 30322, USA.

出版信息

Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):142-8. doi: 10.1177/1533317509333904. Epub 2009 Apr 9.

Abstract

Disease-specific assessments are not currently available for patients with Parkinson's disease dementia (PDD). This study evaluated the criterion-related validity and test-retest reliability of the Alzheimer's Disease Assessment scale cognitive subscale (ADAS-cog) in terms of sensitivity for differentiation between mild and moderate severity impairment in PDD. Six other dementia rating scales and cognitive tests were also examined. A total of 113 patients with PDD or Alzheimer disease were recruited into this 4-week, multicenter study, segregated into 2 severity groups based on Mini-Mental State Examination (MMSE) score. Mean ADAS-cog scores showed a statistically significant separation between mild and moderate severity patients in both dementias (P < .001). For the ADAS-cog, test-retest Spearman correlation coefficients were significant for each dementia type and severity. This study demonstrated the criterion-related validity and test-retest reliability for ADAS-cog in patients with PDD and strong correlations with MMSE. This supports the validity of previous results obtained with these measures in studies of patients with PDD.

摘要

目前尚无针对帕金森病痴呆(PDD)患者的特定疾病评估工具。本研究评估了阿尔茨海默病评估量表认知分量表(ADAS-cog)在区分 PDD 轻度和中度严重程度损伤方面的效标关联效度和重测信度。还对其他六种痴呆评定量表和认知测验进行了评估。共有 113 例 PDD 或阿尔茨海默病患者入组了这项为期 4 周的多中心研究,根据简易精神状态检查(MMSE)评分将他们分为 2 个严重程度组。ADAS-cog 评分在两种痴呆症中均显示出轻度和中度严重程度患者之间的统计学显著差异(P <.001)。对于 ADAS-cog,每种痴呆类型和严重程度的重测 Spearman 相关系数均具有统计学意义。这项研究表明,ADAS-cog 在 PDD 患者中的效标关联效度和重测信度良好,与 MMSE 具有很强的相关性。这支持了以前在 PDD 患者研究中使用这些测量工具获得的结果的有效性。

相似文献

1
Evaluation of dementia rating scales in Parkinson's disease dementia.
Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):142-8. doi: 10.1177/1533317509333904. Epub 2009 Apr 9.
5
Rivastigmine in Alzheimer's disease and Parkinson's disease dementia: an ADAS-cog factor analysis.
Am J Alzheimers Dis Other Demen. 2011 Sep;26(6):443-9. doi: 10.1177/1533317511424892. Epub 2011 Oct 18.
6
How Do Scores on the ADAS-Cog, MMSE, and CDR-SOB Correspond?
Clin Neuropsychol. 2015;29(7):1002-9. doi: 10.1080/13854046.2015.1119312. Epub 2015 Nov 30.
8
Item analysis of ADAS-Cog: effect of baseline cognitive impairment in a clinical AD trial.
Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):119-24. doi: 10.1177/1533317509350298.

引用本文的文献

1
2
Outcome measures for Parkinson's disease dementia: a systematic review.
Mov Disord Clin Pract. 2016 Jan-Feb;3(1):9-18. doi: 10.1002/mdc3.12225. Epub 2015 Sep 16.
3
DEVELOPMENT OF CLINICAL DEMENTIA RATING SCALE CUTOFF SCORES FOR PATIENTS WITH PARKINSON'S DISEASE.
Mov Disord Clin Pract. 2015 Sep 1;2(3):243-248. doi: 10.1002/mdc3.12163. Epub 2015 Apr 20.
4
Comparing clinical profiles in Alzheimer's disease and Parkinson's disease dementia.
Dement Geriatr Cogn Dis Extra. 2013 Sep 11;3(1):281-90. doi: 10.1159/000351861. eCollection 2013.
5
Rivastigmine in Alzheimer's disease and Parkinson's disease dementia: an ADAS-cog factor analysis.
Am J Alzheimers Dis Other Demen. 2011 Sep;26(6):443-9. doi: 10.1177/1533317511424892. Epub 2011 Oct 18.
6
Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data.
CNS Neurosci Ther. 2011 Oct;17(5):428-41. doi: 10.1111/j.1755-5949.2010.00166.x. Epub 2010 Jul 7.
7
Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items.
Am J Alzheimers Dis Other Demen. 2010 Aug;25(5):407-13. doi: 10.1177/1533317510367486. Epub 2010 Apr 14.

本文引用的文献

2
A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease.
Dement Geriatr Cogn Disord. 2008;25(4):301-8. doi: 10.1159/000119104. Epub 2008 Mar 3.
5
Prevalence of dementia in the United States: the aging, demographics, and memory study.
Neuroepidemiology. 2007;29(1-2):125-32. doi: 10.1159/000109998. Epub 2007 Oct 29.
7
Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesterase.
Curr Alzheimer Res. 2007 Jul;4(3):277-93. doi: 10.2174/156720507781077313.
8
Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease.
J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1064-8. doi: 10.1136/jnnp.2006.108076. Epub 2007 Feb 7.
10
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
J Am Geriatr Soc. 2005 Apr;53(4):695-9. doi: 10.1111/j.1532-5415.2005.53221.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验